From redefining value in cancer treatments to predicting the impact of changes in demographics to enhancing Medicare, the Schaeffer Center does more than inform policy — it helps drive decisions to improve delivery of care, foster innovation and enhance healthcare markets.
Other featured articles
Will Robots Replace Doctors?
Senior Fellow Bob Kocher paired with Zeke Emanuel examine why artificial intelligence may lead to more evidence-based care, more personalized care, and fewer errors, it has the potential to unintentionally exacerbate many of the worst aspects of our current healthcare system.
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
Neeraj Sood penned an analysis of Louisiana's new path to curing hepatitis C among its Medicaid and prison populations. It is the first state to implement a solution proposed by Sood in a National Academies of Sciences consensus report and in a leading medical journal.
Ending Drug Rebates will Increase Medicare Part D Premiums, but Most Seniors will be Insulated From It
Erin Trish and Dana Goldman argue eliminating drug rebates will increase the cost of Medicare Part D premiums, but most seniors will be not feel the effects. They say seniors should ignore pharmacy benefit managers' alarm raised by the proposal.
Even if it Survives the Courts, ObamaCare Needs Help
In an op-ed for The Hill, Schaeffer Center professor John Romley and Cedars-Sinai president and CEO Thomas Priselac write that step one to fix the ACA is accepting that payment cuts and cost shaming do not work.